3 results
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.
2. OBJECTIVES2.1 SAFETY OBJECTIVESThe safety objectives for this study are as follows:* To evaluate the safety of MHAA4549A in combination with oseltamivir compared with placebo and oseltamivir in patients with severe influenza A, focusing on the…
The objective of the clinical investigation is to evaluate the safety and performance of the Artimis* medial meniscus prosthesis system and to demonstrate that the Artimis* medial meniscus prosthesis is able to restore the function of the natural…